Emerging data highlights the promise of cellular peptides and dual agonists to reshape therapeutic approaches for systemic diseases. These innovative compounds offer the unique ability to simultaneously stimulate multiple receptors, circumventing the drawbacks of traditional mono-therapy treatments. here By optimizing metabolic signaling, they can